Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,445 total articles
Ascendis Pharma announced positive data from its Phase 2 COACH trial combining TransCon CNP and TransCon hGH, showing sustained, unprecedented growth in children with achondroplasia through Week 78. Additionally, the pivotal ApproaCH trial demonstrated durable benefits from TransCon CNP monotherapy over two years. The company also reported signific…
Theriva Biologics has dosed the first patient in its VIRAGE2 Phase 2a trial, aiming to evaluate more frequent dosing of its oncolytic virus therapy, VCN-01, in combination with standard chemotherapy for metastatic pancreatic ductal adenocarcinoma (PDAC). Building upon encouraging Phase 2b data, this exploratory study seeks to refine dosing regimens…
ALX Oncology reported second quarter 2026 financial results, highlighted advancements in clinical trials for its oncology therapies evorpacept and ALX2004, reinforced its leadership team, and secured a new debt facility. The company remains on track for topline data from its Phase 2 breast cancer trial in mid-2027 and expects initial safety data fr…
Corbus Pharmaceuticals Holdings, Inc. reported Q2 2026 financial results and provided a corporate update highlighting FDA clearance to proceed with the registrational TEMPO-1 Phase 3 trial for CRB-701 in oropharyngeal cancer, and upcoming data from the CANYON-1 Phase 1b study of CRB-913 for obesity. The company also announced key senior leadership …
SHF Holdings, Inc. (Safe Harbor) announced that Canopy HR has selected Safe Harbor's Multiple Employer 401(k) Plan as the recommended retirement solution for its cannabis industry clients. Since its launch in April 2026, the plan has onboarded six new cannabis businesses, including a multistate operator, demonstrating strong early market adoption. …
Merlin, Inc. has successfully reached the Stage of Involvement 3 (SOI 3) milestone with the Civil Aviation Authority of New Zealand for key components of its autonomous flight system. This accomplishment advances Merlin's certification process, demonstrating the safety and reliability of their aviation-grade autonomous flight technology. The compan…
Aemetis, Inc. announced strong financial results for Q2 2026 with revenues increasing 20% year-over-year to $62.7 million driven by growth in California Ethanol and Dairy Renewable Natural Gas segments. The company reported positive operating income of $5.8 million, a turnaround from an operating loss in the prior year period, supported by $8.6 mil…
Genius Group Limited (NYSE: GNS) announced the launch of the first phase of its $14 million Genius City joint venture in Nuanu Creative City, Bali, Indonesia. The project includes Genius Zone, Genius Café, Genius Missions, and Genius School, which opened with a record enrollment of 235 students and strong growth projections. Genius City aims to est…
Vivani Medical announced full enrollment and successful dosing of all 20 participants in its Phase 1 SLIM-1 trial evaluating NPM-139, a miniature subdermal semaglutide implant designed for ultra long-acting delivery over 6 to 12 months. The trial is assessing safety, tolerability, and pharmacokinetics compared to Wegovy injections, with topline dat…
Clearmind Medicine announced that its Independent Data and Safety Monitoring Board (DSMB) has unanimously approved progressing its FDA-regulated Phase I/II clinical trial of CMND-100 in patients with Alcohol Use Disorder (AUD). Following a successful safety evaluation in healthy participants, the study will now advance to Parts B and C, including t…
X-energy, a developer of advanced small modular reactors, has entered a long-term agreement with Centrus Energy to supply enriched HALEU fuel critical for the Xe-100 reactor projects. This partnership de-risks X-energy's 11.5 GW commercial pipeline by securing a domestic, stable supply of HALEU and advances U.S. nuclear fuel commercialization, supp…
LENSAR, Inc., a US-based medical technology company specializing in robotic laser solutions for cataract treatment, will release its second quarter 2026 financial results before market open on August 13, 2026. The company will host a conference call and webcast to discuss results, corporate highlights, and strategic initiatives.
Tejon Ranch Co. announced its second quarter 2026 financial results, reporting net income attributable to common stockholders increased by $4.3 million to $2.6 million compared to a loss in the prior year. Revenues rose $6.3 million to $17.4 million driven by land sales and growth in multifamily, mineral resources, and ranch operations segments. Th…
Prime Medicine reported Q2 2026 financial results highlighting progress in its gene editing pipeline including the initiation of a global Phase 1/2 trial for PM577a targeting Wilson disease, regulatory clearances in the US and New Zealand, and a favorable arbitration outcome securing rights to PM647 for Alpha-1 Antitrypsin Deficiency. The FDA grant…
Exyn Technologies announced that its Exyn Nexys handheld LiDAR scanner has been chosen by a leading U.S. government research and engineering organization following a rigorous head-to-head assessment against other commercial LiDAR systems. The device was selected due to its survey-grade accuracy, mobility, and speed, and will be used for creating de…
MIRA Pharmaceuticals announced positive toxicokinetic data from a 7-day repeated-dose study of their obesity treatment candidate SKNY-1 in Beagle dogs. The drug showed dose-dependent systemic exposure and rapid absorption, de-risking dose selection and supporting advancement into GLP toxicology studies and IND-enabling development. SKNY-1 aims to t…
Black Rock Coffee Bar is continuing its robust expansion in the Valley by opening a new location in Tempe, Arizona, increasing its Arizona footprint to 60 stores. The company promotes its handcrafted specialty beverages and recently added food items while leveraging its loyalty rewards app to enhance customer engagement.
Zscaler, Inc., a leading cybersecurity platform, will release its fourth quarter fiscal year 2026 earnings after market close on September 3, 2026, followed by an investor conference call to discuss the results.
Aligos Therapeutics reported significant progress in Q2 2026, including completing enrollment for its Phase 2 study of pevifoscorvir sodium for chronic HBV infection and receiving key regulatory designations such as Breakthrough Therapy in China and Fast Track in the US. The company secured $25 million upfront from an exclusive Greater China licens…
Nano-X Imaging Ltd., a Nasdaq-listed medical imaging technology company, has priced an $8 million registered direct offering with a single long-term institutional investor. The offering consists of 8 million ordinary shares and warrants exercisable at $1.15 per share. Proceeds will be used for working capital and general corporate purposes. The com…
Freshworks Inc. announced that COO and CFO Tyler Sloat will participate in a fireside chat at the Oppenheimer 29th Annual Technology, Internet & Communications Conference. The session is set for August 12, 2026, with an audio replay available on Freshworks' investor relations site. The company is positioned as an AI-powered unified service operatio…
Globalstar, Inc. reported its second quarter 2026 financial results, generating $64.8 million in revenue with record high Commercial IoT subscriber activations. The company continues regulatory progress on its merger agreement with Amazon and is advancing next-generation satellite constellation initiatives. Despite revenue growth in some segments, …
Praxis Precision Medicines announced positive mid-cycle FDA meetings for its drug candidates ulixacaltamide and relutrigine, with no major safety or efficacy concerns and no advisory committee meetings planned. The company is accelerating commercial preparations for potential approvals in essential tremor and developmental epileptic encephalopathie…
ASP Isotopes Inc. announced that its subsidiary Renergen's subsidiary, Tetra4, has entered a five-year take-or-pay contract to supply liquified natural gas (LNG) to a South African food processor. This contract supports Phase 1 of the Virginia Gas Project, targeting commercial production in Q3 2026, with approximately 75% of Phase 1 LNG volumes now…
Annexon, Inc. reported early positive clinical responses from the initial cohort of U.S. and European Guillain-Barré syndrome (GBS) patients treated with tanruprubart in its ongoing FORWARD study. All ten patients demonstrated rapid and meaningful improvement in strength and functionality within days, reinforcing earlier Phase 3 trial results and s…
